The competition was part of the 3-D Retina Organoid Challenge, which was launched by the National Institutes of Health (NIH) in an attempt to find a model that could help physicians understand and treat diseases of the retina. A few days ago, the NEI announced the winning team.
“The diversity of disciplines within each team is impressive and their concept proposals showcase the creativity that occurs when vision researchers collaborate with experts from other fields,” said NEI Director Paul A. Sieving, M.D., Ph.D. “We intend for these concepts to push the development of retinal organoids. If developed, these next-generation human retina models would be invaluable resources for researchers in academia and industry.”
The winning team, which was awarded $90,000, was led by Erin Lavik, ScD, from the University of Maryland. The team’s proposal involves 3D printing layers of adult neural progenitor-derived retinal neurons that parallel the human retina structure, using a type of screenprinting. The 3D bioprinted retinal models were designed to allow researchers to study and find new ways to prevent the development of eye conditions such as age-related macular degeneration, glaucoma, and diabetic retinopathy – as well as to enable better pharmaceutical testing.
The award for the 3-D Retina Organoid Challenge (3-D ROC) is part of the first phase of the NEI’s plan to get a proposal developed. The second phase will be launching later this year, with $1 million set to go to teams that develop prototypes.
According to the winning proposal, the technology developed is a form of screen printing that doesn’t rely on UV light and avoids issues like shearing.
“During [the second] part [of 3-D ROC] we’re going to actually be asking people to develop their prototypes and that should last for about 2 to 3 years,” said Jessica Mazerik, Health Science Administrator with the NEI. “We want something very functional that recapitulates the structure and morphology, and eventually, hopefully, it can be commercialized and broadly used by the research community and companies. We want something that can be used a little bit more broadly and then that can also be picked up by pharmaceutical companies and used for drug screening drug validation and toxicology screening, and hopefully, modeling diseases.”
“It is simple, reproducible, and highly scalable, making it suitable for high throughput assays. We have shown that we can print both a range of gels and cells in complex patterns with high resolution and reproducibility,” the proposal states. “This allows us to recapitulate the layers of the retina and to provide the matrix cues to promote the critical polarization of the cells types and promote the formation of appropriate synapses in the system, and enhanced survival of target neurons.”
Five honorable mentions were also awarded:
- Northeastern University, led by Rebecca Carrier, PhD
- University of Wisconsin – Madison, led by David Game, MD, PhD
- Albert Einstein College of Medicine, led by Wei Liu, PhD
- University of Miami, led by Daniel Pelaez, PhD
- Fraunhofer Institute for Interfacial Engineering and Biotechnology, led by Katja Schenke-Layland, PhD
You can read the winning proposal here.
Discuss this and other 3D printing topics at 3DPrintBoard.com, or share your thoughts below.[Source: MD Magazine]
You May Also Like
Interview with Alok Anil of Next Big Innovation Labs
This interview features Alok Medikepura Anil. He has great subject matter expertise within the realms of engineering and policy. His knowledge will give some people insight into how 3D bioprinting is reliant upon policy within the future.
Porous Metallic Biomaterials Rely on Additive Manufacturing Processes for Substitute Bone Regeneration Structures
In ‘Additively manufactured porous metallic biomaterials,’ Amir A. Zadpoor explores porous metallic biomaterials in research for bone tissue regeneration, discussing elements such as design, manufacturing, and bio-functionalization—as well as examining...
Aspect Biosystems Heads $2.2 Million Project with New Microfluidic 3D Bioprinting Platform
Aspect Biosystems, headquartered in Vancouver, has created a new microfluidic 3D bioprinting platform to further the progress of tissue engineering. In a collaboration with Merck, GSK, and McGill University’s Goodman...
Electrospinning Fibers for Better Success in 3D Printing Biomimetic Scaffolds
In ‘Three-dimensional printed electrospun fiber-based scaffold for cartilage regeneration,’ Chinese researchers attempt to improve on processes for creating better materials and customized geometries in bioprinting. Here, they not only employ...
View our broad assortment of in house and third party products.